Elekta Gets Clearance for Device that Tracks Tumor Movement During Radiotherapy

Elekta has received 510(k) marketing clearance of a new Comprehensive Motion Management (CMM) function for the company’s Elekta Unity MR-Linac radiotherapy device that tracks a tumor’s movement and allows clinicians to shift the treatment beam to account for movements that occur during a treatment session.

The CMM supports the treatment of targets that are subject to breathing motion or random movements, avoiding the need for patients to hold their breath.

The new function “enables increased precision with no additional set-up time for the user, no hardware to install and no major changes to standard radiotherapy processes,” the company said.